UNIVERSITY OF TENNESSEE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1794-09-10

Employees: 5K

Market Cap: -

Website: http://www.utk.edu

Clinical Trials

Early Versus Interval Appendectomy for Ruptured Appendicitis in Children

Phase 3

Completed

Conditions: Ruptured Appendicitis

Interventions: Procedure: early appendectomy
Procedure: interval appendectomy

First Posted Date: 2007-02-14

Last Posted Date: 2010-01-12

Lead Sponsor: University of Tennessee

Target Recruit Count: 128

Registration Number: NCT00435032

Locations: 🇺🇸
LeBonheur Children's Medical Center, Memphis, Tennessee, United States

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

Phase 2

Terminated

Conditions: Psoriasis

Interventions: Drug: Bicillin L-A

First Posted Date: 2007-01-29

Last Posted Date: 2015-04-21

Lead Sponsor: University of Tennessee

Target Recruit Count: 5

Registration Number: NCT00427609

Locations: 🇺🇸
University of Tennessee Health Science Center, Memphis, Tennessee, United States

A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia

Not Applicable

Completed

Conditions: Cervical Dysplasia

First Posted Date: 2006-09-08

Last Posted Date: 2008-12-15

Lead Sponsor: University of Tennessee

Target Recruit Count: 20

Registration Number: NCT00374114

Locations: 🇺🇸
University of Tennessee Health Sciences Center, Memphis, Tennessee, United States
🇺🇸
University of Tennessee College of Medicine, Chattanooga, Tennessee, United States

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

Not Applicable

Withdrawn

Conditions: Paranasal Sinus Neoplasms

First Posted Date: 2006-07-04

Last Posted Date: 2008-12-10

Lead Sponsor: University of Tennessee

Target Recruit Count: 60

Registration Number: NCT00347256

Magnesium Supplementation to Prevent Bone Loss

Phase 1

Completed

Conditions: Osteoporosis

First Posted Date: 2006-06-30

Last Posted Date: 2008-12-15

Lead Sponsor: University of Tennessee

Target Recruit Count: 74

Registration Number: NCT00346658

Locations: 🇺🇸
University of Tennessee Health Sciences Center, Memphis, Tennessee, United States

Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals

Not Applicable

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Sustained Release Bupropion
Drug: Nicotine Patch

First Posted Date: 2006-03-30

Last Posted Date: 2014-05-21

Lead Sponsor: University of Tennessee

Target Recruit Count: 594

Registration Number: NCT00308763

Locations: 🇺🇸
University of Tennessee Health Science Center / Department of Preventive Medicine, Memphis, Tennessee, United States

Prolonged Smoking Cessation Using Prescription Step Care

Not Applicable

Completed

Conditions: Tobacco Dependence

Interventions: Behavioral: Smoking Cessation Intervention

First Posted Date: 2005-09-15

Last Posted Date: 2014-12-02

Lead Sponsor: University of Tennessee

Target Recruit Count: 270

Registration Number: NCT00170079

Locations: 🇺🇸
University of Tennessee, Memphis, Tennessee, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Strategies to Reduce Weight Gain in Hypertensive Smokers

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Obesity
Heart Diseases
Hypertension

Interventions: Behavioral: Weight Reducing Diet
Behavioral: Exercise
Behavioral: Smoking Cessation

First Posted Date: 2005-07-14

Last Posted Date: 2015-12-02

Lead Sponsor: University of Tennessee

Target Recruit Count: 459

Registration Number: NCT00119821

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Phase 2

Completed

Conditions: Drug/Agent Toxicity by Tissue/Organ
Head and Neck Cancer
Oral Complications
Radiation Toxicity

First Posted Date: 2004-05-25

Last Posted Date: 2013-06-26

Lead Sponsor: University of Tennessee

Registration Number: NCT00003580

Locations: 🇺🇸
William F. Bowld Hospital, Memphis, Tennessee, United States

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-01-22

Last Posted Date: 2013-06-26

Lead Sponsor: University of Tennessee

Registration Number: NCT00003007

Locations: 🇺🇸
William F. Bowld Hospital, Memphis, Tennessee, United States
🇺🇸
Methodist Healthcare - Hospital of Memphis, Memphis, Tennessee, United States
🇺🇸
Baptist Memorial Hospital, Memphis, Tennessee, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy